In RA, use of systemic glucocorticoids ≥5 mg/d (prednisolone-equivalent) was linked to MACE at 8.7 y

Title
In RA, use of systemic glucocorticoids ≥5 mg/d (prednisolone-equivalent) was linked to MACE at 8.7 y
Authors
Keywords
-
Journal
ANNALS OF INTERNAL MEDICINE
Volume -, Issue -, Pages -
Publisher
American College of Physicians
Online
2023-11-07
DOI
10.7326/j23-0082

Ask authors/readers for more resources

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now